Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study
SourceInternational Journal of Cardiology, 299, (2020), pp. 123-130
Article / Letter to editor
Display more detailsDisplay less details
International Journal of Cardiology
SubjectAll institutes and research themes of the Radboud University Medical Center; Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.